US Stock Market Movements | Teva Pharmaceutical (TEVA.US) rises over 4% as innovative drug revenue in Q3 increases by 33% year-on-year

智通财经2026/11/03 15:21

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Zhihu Finance APP reported that on Tuesday, Teva Pharmaceutical (TEVA.US) rose more than 4% to $42.65, reaching a record high. In the news, Teva Pharmaceutical released its financial report for the third quarter of 2026, with non-GAAP earnings per share of $0.86, exceeding market expectations by $0.14. Revenue was $4.4 billion, down 2% year-on-year, beating market expectations by $170 million.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

US Stock Market Movements | Teva Pharmaceutical (TEVA.US) rises over 4% as innovative drug revenue in Q3 increases by 33% year-on-year

You may also like

Crypto prices